A science-led, cash-rich niche feed-additives specialist with a defensible oregano moat—recovering margins and Bio‑Vet diversification set up a potential rerating despite cyclical and disease-driven volatility.
Overview
Anpario plc is a UK-based specialist manufacturer and distributor of natural, sustainable animal feed additives focused on health, nutrition, and biosecurity across poultry, swine, ruminants, and aquaculture. Its model is to “sell the science”: proprietary formulations are validated via rigorous trials to prove producer ROI, which creates stickiness and supports premium pricing. Revenue is derived from four core categories—Health & Performance, Toxin Management, Feed Quality, and Hygiene/Insect Control—sold into a diversified customer base across 80+ countries via a hybrid model (~50% direct through subsidiaries in major hubs, ~50% via distributors). The flagship Orego‑Stim brand, based on an exclusive oregano cultivar and 100% natural essential oil profile, is positioned as a biological alternative to antibiotic growth promoters and is differentiated by documented efficacy, batch consistency, and near-perfect traceability. FY2025 was a record year: revenue rose 24% to £47.2m and PBT rose 54% to £8.0m, highlighting the operational leverage of centralized UK manufacturing and the strategic benefit of Bio‑Vet’s high-margin contribution.